Results 11 to 20 of about 7,838 (234)
CamAPS FX Hybrid Closed-Loop with Ultra-Rapid Lispro Compared with Standard Lispro in Adults with Type 1 Diabetes: A Double-Blind, Randomized, Crossover Study [PDF]
Diabetes Technology & Therapeutics, 2023 Introduction: To evaluate hybrid closed-loop with ultra-rapid insulin lispro (Lyumjev) compared with hybrid closed-loop with standard insulin lispro in adults with type 1 diabetes.
Munachiso Nwokolo +9 more
semanticscholar +7 more sources
A review of insulin lispro for the treatment of patients with type 2 diabetes mellitus [PDF]
Сахарный диабет, 2016 A critical aspect of the treatment of most patients with type 2 diabetes mellitus (T2DM) is the initiation (and subsequent intensification) of insulin therapy when lifestyle interventions and oral anti-hyperglycaemic drugs fail to maintain or improve ...
Marina V. Shestakova +2 more
doaj +2 more sources
Ultra rapid lispro improves postprandial glucose control versus lispro in combination with basal insulin: a study based on CGM in type 2 diabetes in China [PDF]
Frontiers in EndocrinologyAimTo evaluate the efficacy and safety of URLi (ultra rapid lispro insulin) compared to insulin lispro as bolus insulin with basal insulin using CGM in the individuals with type 2 diabetes(T2D) in China.MethodsThis was a double-blind, randomized ...
Lu Yuan +6 more
doaj +2 more sources
Diabetes Technology and Therapeutics, 2020 Background: This study evaluated glucose control by continuous glucose monitoring (CGM) during treatment with ultra-rapid lispro (URLi) or lispro used in combination with insulin glargine or degludec in adults with type 1 diabetes in a substudy of the ...
Maciej T. Małecki +2 more
exaly +2 more sources
Diabetes Therapy, 2021 Introduction The PRONTO-T1D study, which evaluated the efficacy and safety of ultra rapid lispro (URLi) versus lispro in adults with type 1 diabetes (T1D), met the primary endpoint of noninferiority of HbA1c change from baseline compared to lispro at 26 ...
Juliana Bue-Valleskey, Dominik Dahl
exaly +2 more sources
Diabetes, Metabolic Syndrome and Obesity, 2012 J Uy, L Fogelfeld, Y GuerraDivision of Endocrinology, Diabetes and Metabolism, John H Stroger Jr Hospital of Cook County, Chicago; Department of Endocrinology, Diabetes and Metabolism, Rush University Hospital, Chicago, IL, USAAbstract: We have now at ...
Uy J, Fogelfeld L, Guerra Y
doaj +1 more source
Efficacy of insulin lispro in improving glycemic control in gestational diabetes
Indian Journal of Endocrinology and Metabolism, 2014 Aim: To assess the safety and efficacy of insulin lispro in improving glycemic control in patients with gestational diabetes. Materials and Methods: A retrospective observational study was conducted at a single center on 201 gestational women with ...
M C Deepaklal +3 more
doaj +2 more sources
4S-fluorination of ProB29 in insulin lispro slows fibril formation
Journal of Biological ChemistryRecombinant insulin is a life-saving therapeutic for millions of patients affected by diabetes mellitus. Standard mutagenesis has led to insulin variants with improved control of blood glucose; for instance, the fast-acting insulin lispro contains two ...
Stephanie L. Breunig +8 more
semanticscholar +2 more sources
Diabetes Therapy, 2020 We evaluated the efficacy and safety of ultra-rapid lispro (URLi) in comparison to lispro in a subgroup analysis of Japanese adults with type 1 diabetes mellitus from the phase 3 PRONTO-T1D trial.
J. Miura +3 more
exaly +2 more sources
Journal of the American Medical Association (JAMA), 2023 Importance Tirzepatide is a glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist used for the treatment of type 2 diabetes.
J. Rosenstock +7 more
semanticscholar +1 more source